Dual-energy X-ray absorptiometry (DXA) is the gold standard for assessing bone mineral density and is used by clinicians worldwide to assess and monitor bone health in their patients. DXA provides a two-dimensional assessment of bone mineral density, known as areal bone mineral density (aBMD). This two-dimensional representation of a three-dimensional structure limits the clinician’s ability to fully understand, assess, and treat a patient’s bone disease. DXA alone cannot provide a complete picture of bone health, as it does not capture key data on the condition of cortical and trabecular bone.
What if you could bring three-dimensionality to DXA? What if you could determine the specific condition of cortical and trabecular bone in your patients from the same two-dimensional DXA image? Well, now it’s possible with 3D-Shaper® technology.
With three-dimensional analysis, 3D-Shaper® technology overcomes the limitations of traditional DXA-based assessment, enabling clinicians to better understand, treat, and monitor bone health in their patients.
With 3D-Shaper® technology, you can obtain a patient-specific three-dimensional analysis, similar to quantitative computed tomography (QCT-like), from a standard two-dimensional DXA image, without additional radiation, long scan times, or high cost.
